Connect
MJA
MJA

Inappropriate prescribing for osteoporosis

B E Christopher Nordin and Michael Horowitz
Med J Aust 2009; 191 (6): . || doi: 10.5694/j.1326-5377.2009.tb02825.x
Published online: 21 September 2009

In reply: Seeman and colleagues agree that most patients with minimal trauma fractures do not have osteoporosis. The figures are clear: only 13% of patients with a peripheral fracture have a hip bone mineral density (BMD) T-score less than or equal to 2.5 and only 25% have a score less than or equal to 1.5. The corresponding figures for vertebral fractures are 25% and 38%, respectively.1 We do not argue that the 2.5 T-score threshold for defining osteoporosis is sacrosanct, but simply that some bone density threshold be defined for subsidised therapy, for which virtually all the supporting evidence is based on treatment of patients with established osteoporosis. Osteopenia is an artificial concept with an arbitrary definition, but we agree that the T-score threshold for subsidised therapy need not be as low in those with prevalent adult fracture as in those without — perhaps 1.5, which is the threshold recently adopted for patients receiving corticosteroid therapy.


  • 1 Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA.
  • 2 SA Health Working Party on Prevention of Osteoporosis and Fractures, Adelaide, SA.



  • 1. Stone KL, Seeley DG, Lui L-Y, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 2003; 18: 1947-1954.
  • 2. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-1259.
  • 3. Abrahamsen B, Rejnmark L, Pors Nielsen S, et al. Ten-year prediction of osteoporosis from baseline bone mineral density: development of prognostic thresholds in healthy postmenopausal women. The Danish Osteoporosis Prevention Study. Osteoporos Int 2006; 17: 245-251.
  • 4. Nordin BEC. The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women. [Published online ahead of print, Osteoporos Int 21 May 2009.]
  • 5. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007; 92: 1415-1423.
  • 6. Tang BMP, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 370: 657-666.
  • 7. Bishoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551-561.
  • 8. Access Economics. The burden of brittle bones: costing osteoporosis in Australia. Canberra: Access Economics, 2001. http://accesseconomics.com/publicationsreports/getreport.php?report=179&id=227 (accessed Jul 2009).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.